Research Grants show all

NIH8

Patents show all

12Applications7Issued

Clinical Trials show all

3Phase 1/Phase 2

SEC Filings show all

D1

SEC Form D Funding Events

DateOfferedSoldType
2010-12-01$4,500,000$2,000,000Equity, Other

Key Executives

  • Jonathan Soderstrom
    Director
  • Tsang-Bin Tzeng
    Director
  • Robert Tilton
    Executive Officer
  • Shwu-Huey Liu
    Executive Officer